+19.6%
TMO vs CLSK
+211.4%
-191.8%
-37.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CLSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.1% | +6.8% | -5.7% | +0.8% |
| 7D | -0.6% | +7.7% | -8.4% | -1.0% |
| 30D | +1.1% | +12.2% | -11.1% | +0.5% |
| 3M | +28.3% | -15.5% | +43.8% | +28.7% |
| 6M | +23.3% | +39.3% | -16.1% | +20.3% |
| YTD | +5.5% | +35.1% | -29.6% | +2.7% |
| 1Y | +24.5% | +34.0% | -9.5% | +20.0% |
| 3Y | +19.6% | +226.3% | -206.7% | +3.8% |
| All | +19.6% | +211.4% | -191.8% | +3.8% |
Cumulative growth
Daily Returns
Daily percentage return beside CLSK.
Daily Out/Under-Performance
Portfolio return minus CLSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CLSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CLSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling